Health Care/Hospital
Countering counterfeit medicines in the fast-paced world of e-commerce
BANGKOK, Sept. 14, 2020 /PRNewswire/ -- Research shows that counterfeit medicine cannot cure illnesses and can cause moreharm to your health. Counterfeit medicines have been in the market for a long time, and without sufficient awareness, consumption of these substances can lead to unexpected sy...
2020-09-14 16:59
3350
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer * Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib† from largest ongoing st...
2020-09-14 10:41
2479
Global Fund Partnership Has Saved 38 Million Lives - but COVID-19 Could Wipe Out Progress
GENEVA, Sept. 14, 2020 /PRNewswire/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. According to ...
2020-09-14 10:39
3456
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...
2020-09-14 08:30
3408
Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...
2020-09-14 08:17
3382
5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion
* Total planned investment is around 500 million USD over five years to raise manufacturing capacity * Continues long-term strategy of increasing capacity to respond to growing industry demand and new market opportunities * Cytiva hiring nearly 1,000 personnel in Austria, China, Singapore, S...
2020-09-14 03:00
2983
Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting
LONDON, Sept. 12, 2020 /PRNewswire/ -- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selectively Synergize...
2020-09-12 05:00
6134
SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia
Phase 3 clinical trial to support registrational filings in China and Japan Company on track to expand presence in Asia, reflecting its commitment to reach more people with epilepsy worldwide PANGYO, GYEONGGI PROVINCE, Korea, Sept. 12, 2020 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a glo...
2020-09-12 03:13
5385
Harbour BioMed and Hualan Genetic Announced Collaboration to Develop Multiple Innovative Antibody Programs
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, SUZHOU,China and XINXIANG, China, Sept. 11, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company today announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan Geneti...
2020-09-11 21:33
7233
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...
2020-09-11 20:00
5687
Booming Demand for Innodisk's CAN Bus Solutions Amid Pandemic and Autonomous Vehicle Trend
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Innodisk's CAN bus expansion modules are taking the world by storm. Unprecedented demand for autonomous vehicle technology amid the ongoing COVID-19 pandemic and continued growth of industrial automation and smart healthcare mean that Innodisk's industry-le...
2020-09-11 15:45
3760
The Air Liquide Foundation supports 10 scientific projects and 21 social emergency aid projects in the context of its Covid-19 Initiative
PARIS, Sept. 11, 2020 /PRNewswire/ -- In response to the Health crisis, the Air Liquide Foundation launched as early asMarch 2020 the Covid-19 Initiative. More than 2million euros have been mobilized over two years, with a double objective: to support scientific research projects and to reinforce...
2020-09-11 11:53
3451
Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA
CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ -- Sai Life
Sciences, one ofIndia's fastest growing Contract Development & Manufacturing
Organizations (CDMOs)
2020-09-11 11:30
4072
The Korea Ginseng Association, announces new direction for Korean ginseng, a publicly listed functional ingredient for bone health
SEOUL, South Korea, Sept. 11, 2020 /PRNewswire/ -- The Korea Ginseng Association announced that Korean ginseng is registered as a 'publicly listed functional ingredient for bone health" by the Ministry of Food and Drug Safety (MFDS) last July. With this news, development of various health functio...
2020-09-11 11:00
4556
Pharmalutions And Movilitas.Cloud Deliver Serialization Solutions for the Asia-Pacific Region
COLUMBIA, Md., Sept. 11, 2020 /PRNewswire/ -- Movilitas announced Pharmalutions Pte Ltd as its newest Movilitas.Cloud partner for theAsia-Pacific region. Under the partnership, Pharmalutions provides greater access to compliance-ready solutions with Movilitas.Cloud, a GAMP 5 validated software as...
2020-09-11 10:38
3238
Lionel Messi Becomes OrCam Technologies Ambassador to Advocate for Technology-Enabled Accessibility for Blind and Visually Impaired Community
Soccer giant will head global project for people who are blind or visually impaired Messi: "Witnessing each of the members of the 'Dream Team' trying out the OrCam MyEye features, it was clear that this would be a life-changing device for each of them. I am proud to be an OrCam Ambassador to tru...
2020-09-11 07:30
4986
Poor home hygiene contributing to antibiotic resistance, warn global hygiene experts
LONDON, Sept. 11, 2020 /PRNewswire/ -- It is estimated that rates of resistance to commonly-used antibiotics could exceed 40–60% in some countries by 2030.1 With antimicrobial resistance (AMR) set to claim the lives of 10 million by 2050 if no action is taken,2 the GHC's experts are calling for ...
2020-09-11 07:01
3835
Gisele Buendchen Partners With Insight Timer To Encourage Millions To Meditate For Free
Gisele Buendchen And Insight Timer Respond To The Impact Of COVID-19 On Mental Health By Leading Free Guided Meditations And Live Events On Insight Timer In English And Portuguese. NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Insight Timer, the world's largest free meditation app for anxiety, s...
2020-09-10 22:00
4534
Merck Announces Positive Phase II Results for Investigational Sonelokinab (M1095) in Patients with Moderate to Severe Chronic Plaque-Type Psoriasis
Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F - Phase II study was facilitated by Avillion as part of an innovative co-development model DARMSTADT, Germany, Sept. 10, 2020 /PRNewswire/ -- Merck, a leadin...
2020-09-10 20:00
2727
Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke
GERMANTOWN, Maryland, Sept. 10, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the last subject completed their final follow-up assessment in the Company's...
2020-09-10 20:00
3294
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 311 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 283 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 258 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
8059
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
6443
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
5436
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
5082
